scholarly journals Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma

2015 ◽  
Vol 10 (1) ◽  
Author(s):  
Michiko Yamashita ◽  
Yoshiyuki Fujii ◽  
Keiji Ozaki ◽  
Yoshio Urano ◽  
Masami Iwasa ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
T Cell ◽  
Cell Lymphoma ◽  
Secondary Syphilis ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Immunodeficiency Virus

scholarly journals Cytotoxic CD8+ Granulomatous Cutaneous T-Cell Lymphoma Associated With Human Immunodeficiency Virus Infection

2018 ◽  
Vol 40 (9) ◽  
pp. 707-709 ◽  
Author(s):  
Eduardo Rozas-Muñoz ◽  
Ana Mozos ◽  
Ramón M. Pujol ◽  
Justyna Szafranska ◽  
Maria P. García-Muret ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
T Cell ◽  
Virus Infection ◽  
Human Immunodeficiency Virus Infection ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Immunodeficiency Virus

scholarly journals Hemophagocytic Lymphohistiocytosis Complicating T-Cell Lymphoma in a Patient with HIV Infection

2013 ◽  
Vol 2013 ◽  
pp. 1-4 ◽  
Author(s):  
Marc Uemura ◽  
Richard Huynh ◽  
Allen Kuo ◽  
Fernando Antelo ◽  
Robert Deiss ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
T Cell ◽  
Hiv Infection ◽  
Hemophagocytic Lymphohistiocytosis ◽  
Poor Prognosis ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Diagnostic Specificity ◽  
Immunodeficiency Virus ◽  
Initiation Of Therapy

Hemophagocytic lymphohistiocytosis (HLH), while uncommon, may be a devastating complication of lymphoma and/or human immunodeficiency virus (HIV) infection. While several of the diagnostic criteria for HLH are relatively nonspecific, particularly in the setting of a systemic inflammatory response, more diagnostic specificity may be achieved with marked elevations in serum ferritin (e.g., >100,000 ng/mL). Increased suspicion of HLH, particularly in the setting of persistent, unexplained fevers, pancytopenia, and transaminitis, should prompt consideration of HLH. Earlier diagnosis and initiation of therapy have the potential to alter the natural history and poor prognosis of this disorder. We present a patient with HIV infection who developed relapsed T-cell lymphoma complicated by hemophagocytic lymphohistiocytosis.

Primary T-cell lymphoma of muscle in a patient infected with human immunodeficiency virus

1993 ◽  
Vol 95 (5) ◽  
pp. 545-546 ◽  
Author(s):  
George H. Lum ◽  
Thomas M. Cosgriff ◽  
Russell Byrne ◽  
Vishnu Reddy
Keyword(s):  
Human Immunodeficiency Virus ◽  
T Cell ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Immunodeficiency Virus

Cutaneous T-Cell Lymphoma–Like Drug Eruption in an HIV-Positive Patient Taking Vancomycin and Rifampin

2013 ◽  
Vol 17 (6) ◽  
pp. 433-436 ◽  
Author(s):  
Jennifer L. MacIsaac ◽  
Chloé E. Ward ◽  
Melanie Pratt
Keyword(s):  
T Cell ◽  
Cell Lymphoma ◽  
Receptor Gene ◽  
Cell Receptor ◽  
T Cell Lymphoma ◽  
Positive Patient ◽  
Hiv Positive ◽  
Cutaneous T Cell Lymphoma ◽  
Drug Induced ◽  
Immunodeficiency Virus

Background: Cutaneous T-cell pseudolymphoma (CTPL) is a benign reactive T-cell lymphoproliferative subtype of pseudolymphoma. Some variants of CTPL can resemble the plaques of mycosis fungoides (MF). The vast majority of drug-induced cases have been associated with anticonvulsants. There is only one report in the literature documenting a case of vancomycin-induced CTPL. Methods: We report a cutaneous T-cell lymphoma–like eruption in a human immunodeficiency virus (HIV)-positive patient recently started on vancomycin and rifampin. Results: A skin biopsy showed several histologic features of MF with immunohistochemical and T-cell receptor gene rearrangement studies suggestive of CTPL. This atypical T-cell reaction mimicking MF completely resolved on cessation of rifampin followed by vancomycin. Conclusion: Considering drug-induced causes of MF-like histologic changes is crucial to prevent unnecessary treatment for MF.

Sign in / Sign up

Export Citation Format

Share Document